Hamilton Thorne is a leading provider of advanced laser systems for the regenerative medicine, fertility and stem cell research markets. They create technologies that reduce cost, increase efficiency, and enable research breakthroughs in cell and stem cell science. Hamilton Thorne, Inc. is a leading provider of advanced laser systems and instruments for in-vitro cell applications in the regenerative medicine research and fertility clinic markets. Hamilton Thorne’s ZILOS-tk and XYClone laser systems attach to standard inverted microscopes and operate as robotic micro-surgeons, reducing time and increasing efficiency in key stem cell, embryo and living cell procedures. Hamilton Thorne’s CASA systems are designed to bring quality, efficiency and reliability to studies of reproductive cells in the animal, human infertility and reproductive toxicology fields.
The Company’s novel laser systems are rapidly emerging as the dominant products to facilitate precise micro-surgical procedures with stem cells and other living cells in the laboratory. Specific applications include the reduction from nine months to six weeks to develop transgenic animal models, dramatic reductions in cell damage during micro-surgical procedures and 50% higher yields for many cell procedures. The Company sells its products to pharmaceutical companies, biotechnology companies, fertility clinics, university research centres and other commercial and academic research establishments worldwide. Hamilton Thorne’s current customers include some of the leading research labs in the world, including Harvard University, MIT, Yale, Dupont, Monsanto, Charles River Labs, Jackson Labs, Merck, Novartis, Pfizer, Oxford University and Cambridge. Formed in 2002, Hamilton Thorne is a venture-backed company, headquartered in Beverly, Massachusetts. The company employs an engineering, research, production and professional staff of thirty and has access to world-class scientists through its Scientific Advisory Board. Visit www.hamiltonthorne.com for more information